Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival.
Riaz A, Ryu RK, Kulik LM, Mulcahy MF, Lewandowski RJ, Minocha J, Ibrahim SM, Sato KT, Baker T, Miller FH, Newman S, Omary R, Abecassis M, Benson AB 3rd, Salem R. Riaz A, et al. Among authors: kulik lm. J Clin Oncol. 2009 Dec 1;27(34):5734-42. doi: 10.1200/JCO.2009.23.1282. Epub 2009 Oct 5. J Clin Oncol. 2009. PMID: 19805671
Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation.
Riaz A, Memon K, Miller FH, Nikolaidis P, Kulik LM, Lewandowski RJ, Ryu RK, Sato KT, Gates VL, Mulcahy MF, Baker T, Wang E, Gupta R, Nayar R, Benson AB 3rd, Abecassis M, Omary R, Salem R. Riaz A, et al. Among authors: kulik lm. J Hepatol. 2011 Apr;54(4):695-704. doi: 10.1016/j.jhep.2010.10.004. Epub 2010 Oct 23. J Hepatol. 2011. PMID: 21147504 Free PMC article.
AASLD guidelines for the treatment of hepatocellular carcinoma.
Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA. Heimbach JK, et al. Among authors: kulik lm. Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086. Hepatology. 2018. PMID: 28130846 No abstract available.
Emerging approaches in hepatocellular carcinoma.
Kulik LM, Mulcahy MF, Omary RA, Salem R. Kulik LM, et al. J Clin Gastroenterol. 2007 Oct;41(9):839-54. doi: 10.1097/MCG.0b013e318060ac52. J Clin Gastroenterol. 2007. PMID: 17881931 Review.
Hepatocellular carcinoma: latest developments.
Walzer N, Kulik LM. Walzer N, et al. Among authors: kulik lm. Curr Opin Gastroenterol. 2008 May;24(3):312-9. doi: 10.1097/MOG.0b013e3282fafef3. Curr Opin Gastroenterol. 2008. PMID: 18408459 Review.
57 results